Medical Moment Three: Multidisciplinary Collaboration  in the Management of Patients with Heart Failure

Heart failure is a major public-health problem resulting in substantial morbidity and mortality for the US. Unfortunately, challenges and barriers to effective use of guideline-directed medical therapies (GDMT) among hospitalized patients with HFrEF remain. Join Drs. Muthiah Vaduganathan and Amulya Nagarur as they discuss practical strategies and insights into using GDMT, and opportunities for multidisciplinary partnerships when treating these patients.


Supported through an independent educational grant from Merck.

Target Audience

Cardiologists and primary care physicians, alongside their interprofessional heart failure care team of nurse practitioners (NPs) and physician assistants (PAs).

Learning Objectives

  • Interpolate novel agents into established HFrEF guideline-directed medical therapy (GDMT) regimens and emphasize the importance of multidisciplinary collaboration and communication to improve outcomes.
  • Discuss strategies to mitigate and overcome health-related inequities and disparities in heart failure care.

Additional Information

AttachmentSize
Handout2.03 MB
References457.56 KB
General Information1.95 MB
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
Course opens: 
05/10/2021
Course expires: 
05/10/2022
Rating: 
0
On-Demand Enduring Activity
United States

Muthiah Vaduganathan, MD, MPH (Chair)
Instructor in Medicine
Harvard Medical School
Brigham and Women’s Hospital
Cardiovascular Medicine
Boston, Massachusetts

Dr. Vaduganathan is a cardiologist at Brigham and Women’s Hospital and Harvard Medical School (Boston, MA) He is interested in drug development and clinical trials of cardiometabolic therapies. He has authored or co-authored more than 275 peer-reviewed publications. 

Dr. Vaduganathan serves on the editorial board of the European Journal of Heart Failure and JACC Heart Failure (Social Media / CME Editor). He serves on the ACCF/AHA Task Force on Performance Measures and is a co-chair on an FDA Think Tank on improving future clinical trials in HF. He participates as a Clinical Endpoints Committee member for ongoing advanced-phase trials in HF / post-MI LV dysfunction.

 

Amulya Nagarur, MD
Assistant Professor of Medicine 
Co-Chair of Residency Recruitment
Core Educator Faculty
MGH Department of Medicine
Associate Site Director, MGH IM Clerkship
Harvard Medical School
Boston, Massachusetts

Amulya Nagarur, MD is an Assistant Professor of Medicine at Harvard Medical School (HMS) and Academic Hospitalist at Massachusetts General Hospital (MGH). After graduating from Vanderbilt University Medical School, Dr. Nagarur completed her Internal Medicine residency training at MGH and an HMS Fellowship in Medical Education. She works clinically as an Attending Physician with the MGH Core Educator Faculty and Hospital Medicine Unit. In addition to being an academic clinician, she is the Associate Clerkship Director for the HMS Internal Medicine clerkship, an Associate House Director for the HMS Primary Clinical Experience, and Co-Chair of the MGH Intern Recruitment Committee. Dr. Nagarur’s academic interests include curriculum development, faculty development, and research in apprenticeship teaching models.


In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.

Any person who may contribute to the content of this continuing education activity must disclose relevant relationships (and any known relationships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Relevant relationships include receiving from a commercial interest research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.

Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Planners:
Susan H. Gitzinger, PharmD, MPA–has no relevant financial relationships to disclose in relation to the content of this activity.

Muthiah Vaduganathan, MD, MPH–has disclosed that he is a consultant for American Regent, Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, Boehringer Ingelheim, Cytokinetics, Lexicon Pharmaceuticals, and Relypsa. He also receives grant/research support from Amgen, AstraZeneca, and Boehringer Ingelheim and is on the speakers' bureau for Novartis and Roche Diagnostics.

Speakers:
Muthiah Vaduganathan, MD, MPH–has disclosed that he is a consultant for American Regent, Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, Boehringer Ingelheim, Cytokinetics, Lexicon Pharmaceuticals, and Relypsa. He also receives grant/research support from Amgen, AstraZeneca, and Boehringer Ingelheim and is on the speakers' bureau for Novartis and Roche Diagnostics.

Amulya Nagarur, MD–has disclosed that her spouse, Muthiah Vadagunathan, MD, is a consultant for American Regent, Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, Boehringer Ingelheim, Cytokinetics, Lexicon Pharmaceuticals, and Relypsa. Her spouse also receives grant/research support from Amgen, AstraZeneca, and Boehringer Ingelheim and is on the speakers' bureau for Novartis and Roche Diagnostics.

Peer Reviewers:
Terri Cook, PharmD, BCPC, AACC–has no relevant financial relationships to disclose in relation to the content of this activity.

Ravi B Patel, MD, MSc–has no relevant financial relationships to disclose in relation to the content of this activity.

 

 

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 


Medicine (ACCME)
CEC designates this live educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™ per webinar. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Upon completion of a CE Request Form, statements of credit for physicians will be issued.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
Please login or register to take this course.